Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
opioid-induced bowel dysfunction
Strong Relistor Sales Drive New Rally In Progenics
Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha
opioid-induced bowel dysfunction
Progenics
Relistor
Salix
Nektar Phase III Trials At Risk
Nektar Phase III Trials At Risk
Seeking Alpha
AstraZeneca
Enzon
Nektar
NKTR-118
opioid-induced bowel dysfunction
Sucampo says lubiprostone worked in late-stage trial; will file for FDA approval in mid-2012
Sucampo says lubiprostone worked in late-stage trial; will file for FDA approval in mid-2012
Yahoo/AP
Lubiprostone
opioid-induced bowel dysfunction
Sucampo
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Yahoo/Fly on the Wall
Lubiprostone
OBD
opioid-induced bowel dysfunction
Sucampo
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT